JAGX Stock Forecast: Jaguar Health, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 50 of 100 as at 21 Nov 2026 — in the upper half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Jaguar Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (99): Reported profit is backed by cash, and the company is not expanding recklessly.
Volatility (6): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
JAGX stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on JAGX, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 19 May 2025 | First Berlin | Initiates | Buy | $60 |
| 7 July 2021 | Cantor Fitzgerald | Initiates | Overweight | $5.00 |
| 25 Nov 2020 | Aegis Capital | Initiates | Buy | — |
| 25 Nov 2020 | H.C. Wainwright | Reiterates | Buy | — |
| 25 Nov 2020 | Ladenburg Thalmann | Initiates | Buy | — |
| 25 Nov 2020 | Rodman & Renshaw | Initiates | Buy | — |
| 18 Nov 2019 | H.C. Wainwright | Reiterates | Buy | — |
| 18 Nov 2019 | HC Wainwright & Co. | Reiterates | Buy | $10 → $3.00 |
| 12 Sept 2019 | Ladenburg Thalmann | Initiates | Buy | — |
| 11 July 2017 | Rodman & Renshaw | Initiates | Buy | — |
| 12 Nov 2015 | Aegis Capital | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
JAGX appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
JAGX analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 0.1×
- Price / book
- 0.0×
- EV / EBITDA
- —
Cheaper than 94% of US stocks
Cheaper than 99% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 15.8%
- Operating margin
- −88.2%
- Net margin
- —
Higher than 15% of US stocks
Higher than 15% of US stocks
- Return on equity
- −288.1%
- Return on assets
- −36.4%
- Dividend yield
- —
Higher than 5% of US stocks
Higher than 12% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Jaguar Health, Inc. has a market value of $3.0M.
Revenue in the twelve months to 30 June 2026: $27.8M. The latest quarter shrank 58.9% year on year.
Net income over the same four quarters: −$36.9M, a −132.9% net margin.
Free cash flow in the twelve months to 30 June 2026: −$6.7M.
Jaguar Health, Inc. employs 47 people — $591K of revenue per employee.
Data provided by Twelve Data
JAGX and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at JAGX’s peer groups, ranked by the model: healthcare stocks · biotech stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Jaguar Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about JAGX
How does Ticker Nerd's model rank JAGX?
As at 21 Nov 2026, Jaguar Health, Inc. ranks 50 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (99 of 100).
What is the JAGX stock forecast for 2030?
No analyst covering Jaguar Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for JAGX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $263 to $263 over the next 12 months.
What does Jaguar Health, Inc. do?
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company focused on developing and commercializing plant-based gastrointestinal products for humans and animals. Its current business is organized around two segments, Human Health and Animal Health, covering prescription and non-prescription products for conditions such as chronic diarrhea, bowel urgency, and related gastrointestinal distress.
About Jaguar Health, Inc.
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company focused on developing and commercializing plant-based gastrointestinal products for humans and animals. Its current business is organized around two segments, Human Health and Animal Health, covering prescription and non-prescription products for conditions such as chronic diarrhea, bowel urgency, and related gastrointestinal distress. The company’s human portfolio includes therapies for HIV-related diarrhea and other gastrointestinal indications, while its animal health activities target companion and production animals with digestive health needs. Jaguar Health also works through its subsidiaries to support proprietary products derived from sustainably sourced botanical ingredients. Headquartered in San Francisco, California, Jaguar Health plays a specialized role in the pharmaceutical market by addressing gastrointestinal disorders across both human and veterinary care.
CEO Ms. Lisa A. Conte · 47 employees · United States · https://jaguar.health